Lifetime Citizen Portal Access — AI Briefings, Alerts & Unlimited Follows
Senate Judiciary Committee advances HALT fentanyl bill after contested markup; several bipartisan amendments defeated
Loading...
Summary
The Senate Judiciary Committee debated and ultimately reported the HALT fentanyl bill after extended markup, rejecting several bipartisan amendments that sponsors said would expand prevention, harm-reduction and transparency.
The Senate Judiciary Committee spent several hours debating the HALT (Halt Analogous Lethal Toxins) fentanyl bill and a string of proposed amendments addressing prevention, reporting and harm-reduction measures. Committee members repeatedly pressed for a balance between quickly scheduling fentanyl-related substances and adding bipartisan harm-reduction and prevention measures such as school-based education, testing strips and DEA reporting.
Senator Cornyn and other proponents argued permanent scheduling of fentanyl analogs should not be delayed because of additional amendments and warned that postponing action would lead to more overdose deaths. Senator Booker, Senator Hirono and other members pressed to add measures they described as pragmatic, bipartisan, and life-saving — including school education reporting, voluntary test-strip distribution grants for states, additional DEA/DOJ transparency about fentanyl-related substances (FRS), and funding for harm-reduction programs through SAMHSA.
Key debate points and votes: Senator Hirono offered an amendment (EL L25154) asking the Department of Justice, in consultation with the Department of Education, to report on barriers and best practices for fentanyl prevention education in schools; the clerk announced the vote as 10 ayes and 12 nays and the amendment failed. Multiple other amendments raised by senators seeking test-strip funding, DEA reporting, and expanded harm-reduction funding were debated on the record; several of those proposals were called up for votes and were defeated by similar margins in the excerpted transcript.
Committee procedure and quorum: the committee recessed partway through the markup to reconvene at 1:00 p.m. Several senators said they were willing to accept manager’s packages or to take up amendments later, but members pressed to include bipartisan measures now to avoid further delay. At multiple points the clerk noted there was not a sufficient number of members present to vote, and the committee paused and reconvened.
Outcome in the record: the provided transcript records multiple roll-call outcomes for specific amendments (including the Hirono amendment failing 10-12) and ends with the clerk announcing, “The bill is reported. The meeting is adjourned.” The transcript excerpt does not include a final full committee roll-call tally for the underlying HALT bill in the excerpt.
Why it matters: Senators described fentanyl and fentanyl-related substances as a leading cause of death among adults 18–45 and urged the committee to adopt measures that combine scheduling with prevention and harm reduction. Opponents of certain amendments warned that altering the bill could jeopardize the House-Senate managers’ package and delay final enactment, potentially delaying policies supporters say would save lives.
(Ending) The committee’s recorded deliberations show sustained bipartisan interest in adding prevention and harm-reduction steps to a bill aimed at permanently scheduling fentanyl-related substances. The transcript documents the amendments considered, the debate over their merits, and multiple failed amendment votes; the excerpt does not provide a final committee roll-call on the bill’s passage to the Senate calendar.
